US 11,298,330 B2 · Magnesium compositions and methods of use

Abstract

The present invention provides a method of administering magnesium threonate to a subject in need of supplementing magnesium. At least a portion of magnesium (Mg) and threonate (T) is present in a salt form of MgT2. The method may comprise administration of magnesium threonate at two different time points per day. The method may comprise administering, at a first time point, a first oral dosage form comprising magnesium threonate. The method may comprise administering, at a second time point, a combination of the first oral dosage form and a second oral dosage form comprising magnesium threonate. The first and second oral dosage forms may exhibit different dissolution profiles in a dissolution medium.

Claims19

Dependent claims

A method of administering magnesium threonate to a subject in need of supplementing magnesium, wherein at least a portion of magnesium (Mg) and threonate (T) of said magnesium threonate is present in a salt form of MgT2, the method comprising:

(a) administering a first oral dosage form comprising magnesium threonate;
and
(b) administering a combination of (i) said first oral dosage form and (ii) a second oral dosage form comprising magnesium threonate, wherein said first and second oral dosage forms exhibit different in vitro dissolution profiles in a dissolution medium,
wherein said first oral dosage form and said combination of said first and second oral dosage forms are administered at two different time points per day, and
wherein magnesium threonate is present in an amount between about 200 mg to 2000 mg in each of said first and second oral dosage forms.

2 more elements

A kit for administering magnesium threonate to a subject in need of supplementing magnesium, wherein at least a portion of magnesium (Mg) and threonate (T) of said magnesium threonate is present in a salt form of MgT2, the kit comprising:

(a) two of a first oral dosage form comprising magnesium threonate;
(b) one of a second oral dosage form comprising magnesium threonate;
and
(c) a set of instructions for instructing said subject on (i) consuming said first oral dosage form in daytime, and (ii) consuming a combination of said first and second oral dosage forms at once in nighttime,
wherein said first and second oral dosage forms (i) contain magnesium threonate in an amount between about 200 mg to 2000 mg, and (ii) exhibit different in vitro dissolution profiles in a dissolution medium.

2 more elements

Dependencies are inferred from the claim text.

Magnesium compositions and methods of use

Life of this patent

Magnesium compositions and methods of use

Life of this patent

Abstract

Claims19